{"entity":{"type":"insider","cik":"0001849181","url":"/insider/0001849181","json_url":"/insider/0001849181.json","name":"Wang Xiaolin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2021-06-22","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Wang Xiaolin","source":"filing","n_filings":9,"first_seen":"2021-06-22","last_seen":"2026-03-19"}],"transactions":[{"id":5845411,"accession":"0001610717-26-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000126","line_url":"/filing/0001610717-26-000126#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2010.0,"shares_display":"2,010","price_per_share":99.4804,"price_display":"99.48","price_state":"stated","total_value":199955.604,"total_display":"199,955.60","total_whole":"199,956","shares_owned_after":116063.0,"shares_owned_after_display":"116,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":8506567,"accession":"0000899243-23-009372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009372","line_url":"/filing/0000899243-23-009372#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":714.0,"shares_display":"714","price_per_share":21.78,"price_display":"21.78","price_state":"stated","total_value":15550.92,"total_display":"15,550.92","total_whole":"15,551","shares_owned_after":58813.0,"shares_owned_after_display":"58,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":6938859,"accession":"0001567619-22-021928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-021928","line_url":"/filing/0001567619-22-021928#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":708.0,"shares_display":"708","price_per_share":22.9398,"price_display":"22.94","price_state":"stated","total_value":16241.3784,"total_display":"16,241.38","total_whole":"16,241","shares_owned_after":30527.0,"shares_owned_after_display":"30,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6281301,"accession":"0001567619-22-017692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-017692","line_url":"/filing/0001567619-22-017692#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735.0,"shares_display":"735","price_per_share":19.0426,"price_display":"19.04","price_state":"stated","total_value":13996.311,"total_display":"13,996.31","total_whole":"13,996","shares_owned_after":31235.0,"shares_owned_after_display":"31,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-21","scope":"insider"},{"id":6704884,"accession":"0001567619-22-013253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013253","line_url":"/filing/0001567619-22-013253#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":665.0,"shares_display":"665","price_per_share":17.7495,"price_display":"17.75","price_state":"stated","total_value":11803.4175,"total_display":"11,803.42","total_whole":"11,803","shares_owned_after":31970.0,"shares_owned_after_display":"31,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-22","scope":"insider"},{"id":6938228,"accession":"0001567619-22-007325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-007325","line_url":"/filing/0001567619-22-007325#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":18.6142,"price_display":"18.61","price_state":"stated","total_value":4467.408,"total_display":"4,467.41","total_whole":"4,467","shares_owned_after":31698.0,"shares_owned_after_display":"31,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider"},{"id":4944255,"accession":"0001567619-21-022404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022404","line_url":"/filing/0001567619-21-022404#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":257.0,"shares_display":"257","price_per_share":24.41,"price_display":"24.41","price_state":"stated","total_value":6273.37,"total_display":"6,273.37","total_whole":"6,273","shares_owned_after":11938.0,"shares_owned_after_display":"11,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":4563068,"accession":"0001567619-21-017415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-017415","line_url":"/filing/0001567619-21-017415#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":30.02,"price_display":"30.02","price_state":"stated","total_value":7505.0,"total_display":"7,505.00","total_whole":"7,505","shares_owned_after":12195.0,"shares_owned_after_display":"12,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":4943535,"accession":"0001567619-21-012491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012491","line_url":"/filing/0001567619-21-012491#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001849181","owner_name":"Wang Xiaolin","owner_display_name":"Wang Xiaolin","owner_url":"/insider/0001849181","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":34.1209,"price_display":"34.12","price_state":"stated","total_value":8291.3787,"total_display":"8,291.38","total_whole":"8,291","shares_owned_after":12445.0,"shares_owned_after_display":"12,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Officer","n_filings":9,"first_seen":"2021-06-22","last_seen":"2026-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001849181","retrieved_at":"2026-08-23T18:28:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}